Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Chengdu Kanghong Pharm
ISIN CNE1000020C4
|WKN A2DSJX
Market cap (in EUR)
3,458 m
Country
China
Sector
Healthcare
Dividend yield
1.94%
Overview
Description
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, development, production and sale of Chinese patent medicines, chemical medicines and biological products. Its products include Conbercept Ophthalmic Injection, Shugan Jieyu Jiaonang, Ganke Shuangqing Jiaonang, Yiqing Jiaonang, Venlafaxine Hydrochloride Capsules, Xuan Maigangu, Aripiprazole, Keluoxin, Danshu Jiaonang, Mosapride Citrate, and Dexzopiclone. The company was founded on October 3, 1996 and is headquartered in Chengdu, China.
Healthcare Biopharmaceuticals Other Biopharmaceuticals China
Financials
Key metrics
| Market capitalisation, EUR | 3,458 m |
| EPS, EUR | 0.17 |
| P/B ratio | 3.1 |
| P/E ratio | 22.8 |
| Dividend yield | 1.94% |
Income statement (2024)
| Revenue, EUR | 568 m |
| Net income, EUR | 153 m |
| Profit margin | 26.97% |
What ETF is Chengdu Kanghong Pharm in?
There are 3 ETFs which contain Chengdu Kanghong Pharm. All of these ETFs are listed in the table below. The ETF with the largest weighting of Chengdu Kanghong Pharm is the Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating | 0.00% | Equity Emerging Markets | 1,207 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing | 0.00% | Equity Emerging Markets Social/Environmental | 13 |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing | 0.00% | Equity Emerging Markets | 2,640 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.